Image For Activity Cover
Master Session: Cervical Cancer – Paving the Way to a Treatment Shift in Cervical Cancer
Description
Held on October 1, 2022 at the IGCS 2022 Annual Global Meeting in New York City, USA. The session focuses on the state of the art of HPV vaccination in cervical cancer prevention programs. Attendees will be informed about the controversies about the surgical treatment in cervical cancer. Resource-based radiotherapy treatment standard will be provided. Latest news in immunotherapy and new agents in the treatment of cervical cancer will be discussed. A deeper focus on molecular and pathologic characteristics of cervical cancer will be discussed.

Master Session: Cervical Cancer – Paving the Way to a Treatment Shift in Cervical Cancer

Chair(s)

Domenica Lorusso (Italy)
Bradley J. Monk (United States of America)
Rene Pareja (Colombia)
Alexandra Taylor (United Kingdom)
Krishnansu Tewari (United States of America)

Why do we still discuss a disease that can be prevented? State of the art of HPV vaccines and precancerous lesion treatment

Agnaldo Lopes (Brazil)

Is cervical cancer a single disease? Pathologic and molecular characterization of a complex tumor

Kay J. Park (United States of America)

Radiotherapy in cervical cancer treatment: resource adapted standard of care

Alexandra Taylor (United Kingdom)

Q&A/Discussion

Bradley J. Monk (United States of America) Pedro T. Ramirez (United States of America)

Hot topics in surgery: Fertility sparing treatments, surgical staging and mini invasive surgery

Christhardt Köhler (Germany)

The role of immunotherapy in cervical cancer

Domenica Lorusso (Italy)

What next: New treatment options in the horizon scanning of cervical cancer

Krishnansu Tewari (United States of America)

Q&A/Discussion

 

Summary
Availability: On-Demand
Cost: FREE
Recommended
Contact education@igcs.org for assistance.
Powered By